Pro Health Tips
Monday, 31 August 2020
Empagliflozin Downs the Risk of Cardiovascular Death, Hospitalization
Empagliflozin reduced the combined relative risk of cardiovascular death and hospitalization for heart failure patients with and without diabetes by 25 percent.
from Medindia Health News https://ift.tt/3lDwuPt
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Empagliflozin reduced the combined relative risk of cardiovascular death and hospitalization for heart failure patients with and without diabetes by 25 percent.
No comments:
Post a Comment